Johnson & Johnson EVP sells 33,597 shares
EVP and MedTech chair Timothy Schmid exercised options and sold 33,597 Johnson & Johnson shares, while retaining small indirect holdings through retirement plans.
Rhea-AI Filing Summary
JOHNSON & JOHNSON (JNJ) executive Timothy Schmid, EVP and Worldwide Chair of MedTech, reported exercising employee stock options and selling the resulting common shares on September 2, 2026. He exercised options for 11,070 shares with an exercise price of $131.94 per share and for 22,527 shares with an exercise price of $151.41 per share, both granted under the company’s Long-Term Incentive Plan and expiring in 2029 and 2030, respectively. He acquired an equal number of common shares from these exercises and then sold 11,070 shares and 22,527 shares of common stock the same day at a reported price of $274.74 per share, resulting in a net sale of 33,597 shares. Indirect holdings reported as of the most recent plan reporting date include 758 shares through a 401(k) plan and 46 shares through an employee stock ownership plan. No Rule 10b5-1 trading plan is indicated.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 33,597 shares ($4.36M approx. pre-tax spread)
Exercise and Sale
8 txns
Insider
Schmid Timothy
Role
EVP, WW Chair, MedTech
Sold
33,597 shs ($9.23M)
Approx. gross sale proceeds
$9.23M
Approx. exercise cost
$4.87M
Approx. pre-tax spread
$4.36M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Options (Right to Buy) F3 | 11,070 | $0.00 | $0.00 |
| Exercise | Employee Stock Options (Right to Buy) F3 | 22,527 | $0.00 | $0.00 |
| Exercise | Common Stock | 11,070 | $131.94 | $1.46M |
| Sale | Common Stock | 11,070 | $274.74 | $3.04M |
| Exercise | Common Stock | 22,527 | $151.41 | $3.41M |
| Sale | Common Stock | 22,527 | $274.74 | $6.19M |
| holding | Common Stock F1 | -- | -- | -- |
| holding | Common Stock F2 | -- | -- | -- |
Holdings After Transaction:
Employee Stock Options (Right to Buy) — 0 contracts (Direct);
Common Stock — 25,447 shares (Direct);
Common Stock — 758 shares (Indirect, By 401k);
Common Stock — 46 shares (Indirect, By ESOP)
Footnotes (3)
- F1. Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (8/31/2026).
- F2. Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (8/31/2026).
- F3. Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Key Figures
Shares sold: 33,597 shares
Sale price per share: $274.74 per share
Option exercise price 1: $131.94 per share
+5 more
8 metrics
Shares sold
33,597 shares
Total Johnson & Johnson common shares sold on September 2, 2026
Sale price per share
$274.74 per share
Price for Johnson & Johnson common stock sales on September 2, 2026
Option exercise price 1
$131.94 per share
Exercise price for 11,070 options on Johnson & Johnson common stock
Option exercise price 2
$151.41 per share
Exercise price for 22,527 options on Johnson & Johnson common stock
Options exercised
33,597 shares
Total underlying Johnson & Johnson shares from options exercised
Indirect 401(k) holdings
758 shares
Johnson & Johnson shares in a 401(k) stock fund as of August 31, 2026
Indirect ESOP holdings
46 shares
Johnson & Johnson shares held by an employee stock ownership plan as of August 31, 2026
Option expiration dates
February 11, 2029 and February 10, 2030
Expiration dates of the exercised employee stock options
Key Terms
Employee Stock Options, Long-Term Incentive Plan, dividend reinvestment, employee stock ownership plan
4 terms
Employee Stock Options financial
"Employee Stock Options (Right to Buy)"
Employee stock options are contracts that give workers the right to buy a company's shares at a set price sometime in the future, like a coupon that lets you purchase stock at today’s price later on. Investors care because they align employees’ incentives with company performance and create a potential future claim on shares that can reduce existing owners’ percentage and add to a company’s reported compensation costs.
Long-Term Incentive Plan financial
"Awarded under Issuer's Long-Term Incentive Plan."
A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.
dividend reinvestment financial
"Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund"
Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.
employee stock ownership plan financial
"Shares held by ESOP under the Johnson & Johnson Savings Plan"
An employee stock ownership plan (ESOP) is a company-run program that gives workers ownership stakes by allocating or letting them buy company shares, often through a retirement-style account. For investors, ESOPs matter because they align employees’ incentives with company performance—like turning staff into shareholders—which can boost productivity and long-term value but may also concentrate employee retirement savings in company stock, affecting financial risk and share demand.
FAQ
What did JNJ executive Timothy Schmid report in this Form 4?
He reported exercising employee stock options for 33,597 shares of Johnson & Johnson common stock and selling all 33,597 shares on September 2, 2026, in open-market or private transactions.
What were the exercise prices of the options exercised by Timothy Schmid at JNJ?
He exercised options covering 11,070 shares at an exercise price of $131.94 per share and options covering 22,527 shares at an exercise price of $151.41 per share, both relating to Johnson & Johnson common stock.
Were Timothy Schmid’s Johnson & Johnson transactions under a Rule 10b5-1 plan?
The filing indicates that no Rule 10b5-1 trading plan was affirmed for these transactions, meaning they are not reported as having been made under a pre-arranged trading plan.
What indirect Johnson & Johnson holdings does Timothy Schmid report after these transactions?
He reports indirect holdings of 758 shares of Johnson & Johnson common stock through a 401(k) savings plan and 46 shares through an employee stock ownership plan, as of the plans’ most recent reporting date of August 31, 2026.
What plans or programs are involved in Timothy Schmid’s JNJ holdings?
The options were awarded under a Long-Term Incentive Plan, and some shares are held through the Johnson & Johnson Savings Plan in a 401(k) stock fund and an employee stock ownership plan, including shares accrued via dividend reinvestment.
AI-generated analysis. How Rhea-AI works. Not financial advice.
